133 related articles for article (PubMed ID: 3476783)
1. Epidermal growth factor receptor expression in human lung carcinomas defined by a monoclonal antibody.
Sobol RE; Astarita RW; Hofeditz C; Masui H; Fairshter R; Royston I; Mendelsohn J
J Natl Cancer Inst; 1987 Sep; 79(3):403-7. PubMed ID: 3476783
[TBL] [Abstract][Full Text] [Related]
2. A novel monoclonal antibody-defined antigen which distinguishes human non-small cell from small cell lung carcinomas.
Sobol RE; Peters RE; Astarita RW; Hofeditz C; Masui H; Burton D; Handley HH; Glassy MC; Fairshter R; Carlo DJ
Cancer Res; 1986 Sep; 46(9):4746-50. PubMed ID: 3015395
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptors in lung tumours.
Berger MS; Gullick WJ; Greenfield C; Evans S; Addis BJ; Waterfield MD
J Pathol; 1987 Aug; 152(4):297-307. PubMed ID: 3668732
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
Rusch V; Klimstra D; Linkov I; Dmitrovsky E
Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
[TBL] [Abstract][Full Text] [Related]
5. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
[TBL] [Abstract][Full Text] [Related]
6. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas.
Garcia de Palazzo IE; Adams GP; Sundareshan P; Wong AJ; Testa JR; Bigner DD; Weiner LM
Cancer Res; 1993 Jul; 53(14):3217-20. PubMed ID: 8391918
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 4 receptor expression on human lung tumors and normal lung.
Tungekar MF; Turley H; Dunnill MS; Gatter KC; Ritter MA; Harris AL
Cancer Res; 1991 Jan; 51(1):261-4. PubMed ID: 1846310
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.
Wikstrand CJ; Hale LP; Batra SK; Hill ML; Humphrey PA; Kurpad SN; McLendon RE; Moscatello D; Pegram CN; Reist CJ
Cancer Res; 1995 Jul; 55(14):3140-8. PubMed ID: 7606735
[TBL] [Abstract][Full Text] [Related]
9. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
Willmore-Payne C; Holden JA; Layfield LJ
Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
[TBL] [Abstract][Full Text] [Related]
10. Differentiation-related expression of epidermal growth factor receptors in human lung carcinoma demonstrated histochemically by biotinylated epidermal growth factor.
Kayser K; Weisse G; Gabius HJ; Bubenzer J; von Eberstein M; Hintze T
Mod Pathol; 1990 May; 3(3):327-31. PubMed ID: 2362939
[TBL] [Abstract][Full Text] [Related]
11. Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
Modjtahedi H; Eccles S; Sandle J; Box G; Titley J; Dean C
Cancer Res; 1994 Apr; 54(7):1695-701. PubMed ID: 8137284
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
[TBL] [Abstract][Full Text] [Related]
13. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptor.
Udayachander M; Dean CJ; Meenakshi AN; Sivakumar N; Babu PB; Sivakumar J
Hum Antibodies; 1997; 8(2):60-4. PubMed ID: 9289389
[TBL] [Abstract][Full Text] [Related]
15. [The expression of monoclonal antibody KM-93 reactive antigen in human lung carcinoma--an immunohistochemical evaluation].
Sasaki K; Matsumura K; Ogino T; Tsuji T; Shinozaki F; Takahashi M
Gan No Rinsho; 1988 Jul; 34(8):965-8. PubMed ID: 2457119
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component.
Ohtsuka K; Ohnishi H; Fujiwara M; Kishino T; Matsushima S; Furuyashiki G; Takei H; Koshiishi Y; Goya T; Watanabe T
Cancer; 2007 Feb; 109(4):741-50. PubMed ID: 17238183
[TBL] [Abstract][Full Text] [Related]
17. Cell surface glycoprotein associated with human lung tumors that is similar to but distinct from the epidermal growth factor receptor.
Chen FA; Repasky EA; Takita H; Schepart BS; Bankert RB
Cancer Res; 1989 Jul; 49(13):3642-9. PubMed ID: 2659165
[TBL] [Abstract][Full Text] [Related]
18. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas.
Liu C; Tsao MS
Am J Pathol; 1993 Apr; 142(4):1155-62. PubMed ID: 8097369
[TBL] [Abstract][Full Text] [Related]
20. Expression of epithelial and neural antigens in small cell and non small cell lung carcinoma.
Moss F; Bobrow LG; Sheppard MN; Griffiths M; Rowe D; Beverley PC; Addis B; Souhami RL
J Pathol; 1986 Jun; 149(2):103-11. PubMed ID: 2426429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
